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Abstract 
Background : To determine association of 25 
hydroxy vitamin D deficiency with age in patients 
with community acquired pneumonia (CAP). 
Methods:  In this descriptive study 150 diagnosed 
patients of community-acquired pneumonia based 
on the CURB-65 scoring criteria were enrolled.  The 
25 hydroxy vitamin D levels were recorded in all 
patients. Patients were divided into three groups 
according to their age. Effect modifiers like gender 
were controlled by stratification. Post stratification 
chi square test was applied. A p value of 0.05 was 
considered significant. 
Results: Mean age of the patients was 40.05 ± 14.33 
years (mean ± SD). Out of 150 patients 54.7% (n=82) 
were males while the 45.3% (n=68) were females.  
The mean level of vitamin D was 18.43 ± 5.005 (mean 
± SD) ng/ml.  When the cut off value for deficiency 
was applied i.e. 20 ng/ml, the 60% (n=90) patients 
were found deficient while 40% (n=60) patients had 
normal values. The p value was significant only for 
the age group to 35 to 50 years. Independent sample t 
test showed that the difference is statistically 
significant (p=0.003) in age groups between 35 to 50 
years. 
Conclusions: Lower concentrations of vitamin D 
might be associated with CAP particularly in age 
group between 35 to 50 years. 
Key Words: Pneumonia, Vitamin D Deficiency, 
Chronic, Prognosis 
 
Introduction 
In recent years there are number of growing evidences 
that vitamin D not only helps in metabolism of calcium 
and bone but also has several immune modulatory 
effects. It has been described recently that apart from 
the kidneys, leukocytes also contain 1α-hydroxylase. 
This 1α-hydroxylase converts 25 hydroxy vitamin D to 
biologically active 1,25 dihydroxy vitamin D i.e 
1,25(OH) D. There are number of factors ranging from 
dietary deficiency, inadequate exposure to sunlight 
and malabsorption syndromes such as celiac disease 
resulting in Vitamin D deficiency. Lower serum levels 
of Vitamin D are an important risk factor of upper 
respiratory tract infections. 1-25 dihydroxy vitamin D 
modulates antimicrobial effects of the innate immune 
system. By modulating the crosstalk between T cells 
and cells of the innate immune system, vitamin D 
attenuates an over-whelming inflammatory response 
.There are number of growing evidences that apart 
from having effects on calcium and bone metabolism, 
vitamin D also hosts several immune modulatory 
effects1. To become biological active, vitamin D is 
initially hydroxylated to 25-OH vitamin D by the 25-
hydroxylase (CYP27A1) present in the liver. 1α-
hydroxylase (CYP27B1) present in the kidney 
catalyzes the second hydroxylation and converts 25-
OH vitamin D to biologically active form 1-25 
dihydroxy vitamin D (1,25-OH2). As the half live of 1, 
25-OH2 is short i.e 4-6 hours, 25-OH which is much 
less active precursor having a plasma half life of 3 
weeks is considered as a reservoir of vitamin D. It has 
been suggested recently that apart from the kidneys, 
leukocytes also contain 1α-hydroxylase and therefore 
can play a role in activation of 25-OH. 1,2  
Vitamin D deficiency can result from various factors 
including decreased exposure to sunlight or 
malabsorption syndromes; such as short gut 
syndrome, celiac disease and cystic fibrosis. Some 
medications such as rifampicin, phenobarbital, and 
phenytoin can induce hepatic P 450 enzymes and 
increases the catabolism of vitamin D. 3 There is no 
definitive definition for the measurement of vitamin D 
level which is measured as serum 25-OH. A recent 
guideline suggested that vitamin D deficiency is 
defined as 25-OH below 20 ng/ml, insufficiency as 21–
29 ng/ml, and sufficiency as 30–100 ng/ml.1, 4 
Community-acquired pneumonia (CAP) carries 
significant mortality and morbidity and is one of the 
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most common infectious disease worldwide. 
Important Bacteria that leads to the condition include 
Streptococcus pneumoniae, causing community 
acquired pneumonia and Mycoplasma, Legionella and 
Chlamydia psittaci causing atypical pneumonias.5  
Patients with typical community acquired pneumonia 
presents with cough productive of purulent sputum, 
high-grade fever and pleuritic chest pain. On physical 
examination coarse crackles and bronchial breathing is 
heard over involved lobe or segment. Atypical 
community acquired pneumonias present with a 
variety of pulmonary or extrapulmonary features 
including diarrhea, rash, confusion, lethargy, 
endocarditis, myocarditis, heart blocks, relative 
bradycardia, etc.6, 7 
CURB-65 criteria is used to assess severity of 
community acquired pneumonia, developed by the 
British Thoracic Society. It comprises of five 
components confusion, serum urea levels, respiratory 
rate, blood pressure, and age of the patient. It scores 0-
5 more than 2 points is considered for in patient care 
and categorized as severe pneumonia.6, 8 
There is an increased risk of upper respiratory tract 
infection in patients with low serum 25(OH) D levels. 
This is because of facilitation of antimicrobial effects of 
the innate immune system mediated by 1-25 
dihydroxy vitamin D.2 By modulating the crosstalk 
between T cells and cells of the innate immune system, 
vitamin D attenuates an over-whelming inflammatory 
response.1 Deficiency of vitamin D can impair immune 
function which may result in immune suppression 
with poorer resistance to infection as well as over 
activity and an increase in risk of various autoimmune 
diseases. Through this route, vitamin D levels 
influence the bacterial flora and affect immune 
function2, 3. According to one study conducted by 
Remmelts HH et al, deficiency of vitamin D was 
present in 44% patients with CAP.  There is no 
sufficient data regarding vitamin D deficiency in 
severe and mild community-acquired pneumonia. 
This study showed Vitamin D deficiency was present 
in 44% patients with mild and 56% of patients with 
severe community acquired pneumonia.9 
 
Patients and Methods 
 
 A total of 150 patients with recent diagnosis of 
community-acquired pneumonia based on the CURB-
65 scoring criteria of more than two points were 
enrolled into the six months study from 7 August 2015 
to 06 February 2016 at Benazir Bhutto Hospital after 
getting ethical review board approval. Data was 
recorded in self-structured questionnaire. The 25 
hydroxy vitamin D levels were recorded in all 
patients. Data was analyzed by SPSS version 12. 
Numerical data like age, Vitamin D levels was 
presented as mean ± standard deviation. Categorical 
data was presented as frequencies.  Effect modifiers 
like age and gender were controlled by stratification. 
Post stratification chi square test was applied. A p 
value of 0.05 was considered significant. 
 
Results 
Mean age of the patients was 40.05 ± 14.33 years (mean 
± SD). Majority (46.3%) were less than 35 years of age 
(Table 1). Males constituted 54.7%(n=82) and females 
constituted 45.3%(n=68)  of study population. Mean 
level of vitamin D was 18.43 ± 5.005 (mean ± SD) ng 
/ml.  When the cut off value for deficiency was 
applied i.e. 20 ng/ml, the 60% (n=90) patients were 
found deficient while 40% (n=60) patients had normal 
values (Figure 1).The p value was significant only for 
the age group 35 to 50 years. Independent sample t test 
showed that the difference is statistically significant 
(p=0.003) in age groups between 35 to 50 years. (Table 
1) 
 
Table 1:Age Distribution 
Age (years) No(%) 
< 35 68(46.3) 
35-50 39 (26.0) 
>50 43(28.7) 
 
64
47
39
0
10
20
30
40
50
60
70
< 17 ng/ml 17-22 ng/ml > 22 ng/ml
Frequency
Figure 1: Levels of Vitamin D 
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Table 1: Vitamin D levels in various age groups  
 
Age 
 
Vitamin D deficiency 
 
 
Total 
 
P value 
 Yes No   
 
<35 
years 
39 29 68 
 
0.073 
35 to 50 
years 
19 20 39 0.015 
>50 
years 
32 11 43 
 
0.922 
 
Discussion 
The community-acquired pneumonia (CAP) is one of 
the most deadly infectious disease worldwide. It is one 
of the major killers with mortality up to 51 % in 
complicated cases 10. The CAP can lead to a variety of 
complications but the patients with more defective 
immunity are more at risk. This rule also applies to the 
patients with diabetes, chronic renal and liver 
failures.11The list of complications of CAP is much 
diverse and there are various predictors of mortality 
and morbidity. These include pneumonia severity 
index (PSI), CURB-65, PIRO scale and various 
modifications of these scales.12, 13  Shah, B. A., et al. in 
2010 compared the CURB-65 and PSI for mortality and 
morbidity of pneumonia. They found that both scoring 
systems have advantages and disadvantages. They 
concluded that both PSI and CURB-65 were equally 
sensitive in predicting death from CAP. Specificity of 
CURB-65 was higher than that of PSI. However, 
sensitivity of PSI in predicting ICU admission was 
higher than CURB-65.8 In our study, CURB-65 was 
used as it was more easily applied on adult 
populations and parameters are easy to evaluate and 
elaborate. Based on the score system, the patients 
having score of more than two and requiring hospital 
admissions were selected. 
Community-acquired pneumonia is more commonly 
seen in very young and the elderly but is largely under 
recognized in individuals in middle aged working 
people.14 Streptococcus pneumonia is the most 
common causative organism in adults.10The 
association of vitamin D with immunity has been 
validated in all major literature. Mahmud, MR., et al. 
in 2016 evaluated the role of vitamin D in immunity 
and Dengue fever. The study was conducted in 50 
patients and showed that mean vitamin D levels in 
dengue fever patients were higher (21.5 ± 13.6 ng/ml) 
as compared to Dengue hemorrhagic fever (12.4 ± 5.6 
ng/ml) providing evidence that vitamin D deficiency 
decreases immunity leading to dengue hemorrhagic 
fever 15. Another study conducted at Benazir Bhutto 
Hospital, Rawalpindi on 124 patients showed 
significant therapeutic role of Vitamin D in 
progression of infectious diseases. 16 
Leow, L., et al. showed relationship between vitamin 
D and risk of CAP. They found that the titres of 
cathelicidin or beta-defensin-2, which depict the 
immunity levels remain unaffected by vitamin D but 
the pneumonia related mortality was more significant 
if patients were vitamin D deficient. In more details, 
15% of population had severe 25-hydroxyvitamin D 
deficiency (<30nmol/L) and had a higher 30-day 
mortality as compared with the patients with sufficient 
25-hydroxyvitamin D (>50nmol/L) (P=0.004).17 In 
2012, Remmelts, H. H., et al. found that the vitamin D 
levels are correlated closely with the ICU admissions 
and mortality. This study was done on 272 patients 
and both PSI and CURB-65 scores were used 9. The 
effect of vitamin D in reducing CAP risk scores were 
validated on healthy population in another study on 
more than 16 thousand individuals.18 
Jovanovich, AJ., et al. evaluated the role of vitamin D 
level and risk of community-acquired pneumonia and 
sepsis. All results showed that vitamin D levels and 
supplementation could reduce risk of infections 
including CAP and sepsis.19 A recent study by Kim, H. 
J., et al. in 2015 showed that the vitamin D deficiency is 
good predictor of 28 days mortality in CAP (p value 
0.01). They found that up to 80% of hospitalized 
patients were vitamin D deficient.20 
The role of vitamin D on CAP related mortality and 
morbidity is still obscured but some recent genetic 
research data shows that one of the potential genetic 
risk factors for CAP might be TT genotype of 
rs2239185 in VDR gene, and there may be association 
of T allele of rs2239185 with the susceptibility to CAP 
and the severity of CAP.21  
In our study, the vitamin D deficiency was 
significantly more in high-risk population of CAP (p 
value 0.009). The age stratification showed that this 
correlation is only significant for the age group of 35 to 
50 years (p value 0.015). All other age groups showed 
no significant impact. This is in accordance to study 
conducted by Broulette, J et al which concludes that 
middle-aged group is under recognized in community 
acquired pneumonia.14 
 
Conclusion 
Vitamin D may have a role in management of 
community-acquired pneumonia. The present study 
suggests that low concentrations of vitamin D might 
be associated with increased risk of community-
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acquired pneumonia; however a multi-centric trial 
with larger sample size is needed to further investigate 
the relationship between Vitamin D and community-
acquired pneumonia.  
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